DSM Innovation Partnering Conference: ‘Connecting Bright Innovations 2017’


DSM invites entrepreneurs to connect with key executives to explore business collaborations and investment opportunities. Entrepreneurs and technology developers in food ingredients, nutrition, biotechnology and other innovations are invited to apply to be selected to present to DSM from applications submitted through the extended deadline of July 15, 2017.

DSM’s Connecting Bright Innovations 2017 is focused on inviting collaborations with DSM and  innovative companies providing products and technologies that address human health issues. The event will be held at DSM’s new Biotechnology Center in Delft, where DSM Food Specialties has its global headquarters, on September 19-20, 2017.
The first set of selected companies will be announced by July 7, 2017 and invited to the conference.

DSM’s Connecting Bright Innovations 2017 is the fifh in a series of Innovation Partnering Conferences held by DSM and focused on human health and nutrition. Previous events include two in New Jersey, and one each in Switzerland and Japan and have led to successful collaborations between DSM and attendees, and equity investments by DSM Venturing.

The focus areas for this conference include innovative technologies and products with near-term (<3 years to commercialization) and long-term (>3 years to commercialization) applications in the following areas: (Note these are priority areas, but DSM will consider applications from innovations in other areas of human health and nutrition.)

  • Sugar reduction and natural alternative sweeteners
  • Bio-preservation solutions for food and beverages
  • Salt reduction and other natural taste modulation solutions
  • Solutions to improve digestive health and bio-availability
  • Food chain efficiency and food waste reduction solutions
  • Fermentation and enzymatic technologies for new ingredients
  • The role of new proteins in healthier, better tasting, more sustainable food products and production systems

DSM’s Connecting Bright Innovations 2017 will include presentations from senior DSM executives on how DSM collaborates with entrepreneurs at all stages of the supply chain, works to co-develop products and invests in startups with innovative human health and nutrition solutions.

Each presenting company that completes the application and screening process and is invited will present a 15 minute overview followed by 30 minutes of discussion with senior DSM personnel, including DSM executives from R&D, Innovation, Sales & Marketing, Regulatory and DSM Venturing.

Presenting companies will be assigned mentors from Nutrition Capital Network (NCN) and DSM to help develop their presentation prior to the conference. Post-event mentoring from a DSM executive will be available on a case-by-case basis and all selected candidates will be considered for an investment by DSM Venturing or for another type of collaboration with DSM.

A selection committee of DSM and NCN executives will evaluate and interact with applicants to select and prepare the 10-12 invited companies.

The application process and participation is free.
Applications are due by June 23, 2017.
All travel arrangements will be the responsibility of the conference attendees.

Apply here

NCN is partnering with DSM to support the selection process and production of this meeting. For questions or assistance on the application process and potential outcomes, please contact mdovbish@nutritioncapital.com.

The Innovation Partnering Conference ‘Connecting Bright Innovations 2017’ will be held at the Rosalind Franklin Biotechnology Center on the DSM site in Delft. The center’s location at the heart of the Biotech Campus Delft allows DSM to rapidly develop and scale up biotechnology solutions for promising new ingredients for customer validation and commercial roll-out. The Biotech Campus Delft, an initiative of DSM Delft, Delft University of Technology, the City of Delft and the Province of South Holland, builds on the location’s existing competences and internationally recognized position as a world leader in biotechnology development. It brings together fundamental science and R&D, applications expertise, piloting and scale-up facilities as well commercial and market insights and relationships on one location.